The eHealth Venture Summit at MEDICA HEALTH IT FORUM brings together key firms from the pharmaceutical, communication, insurance, med-tech and the hospital industry with state of the art eHealth start ups. The key purpose is to present a clear and forward thinking strategy overview of an innovative environment with special regards to infrastructure and funding and to implement eHealth on a national and international level. The summit will provide an overview about global eHealth developments, a short outlook of industry specific strategies of key healthcare industry players and panel presentations of worldwide leading eHealth start ups.
Foto: Winner of the eHealth Venture Summit Award 2016: XBird
Meet the hottest trends and innovations in Health IT as well as investment at the “eHealth Venture Summit”. This event at the MEDICA HEALTH IT FORUM showcases new companies, offers valuable insights and shall foster strategic partnerships and investment opportunities crucial to bringing innovative products to market.
The event will feature seasoned industry experts from leading companies and funding specialists. The conference is jointly organized by CureMyWay, Jerusalem (Israel) and the University Hospital Essen in cooperation with CatCap GmbH, EurA AG and MEDICA HEALTH IT FORUM.
eHealth Venture Summit Innovation Award
The “eHealth Venture Summit Innovation Award” offers eHealth Start-ups the opportunity to obtain critical peer review and to get in contact with potential investors. The finalists will have the opportunity to meet the experts face-to-face, to prove the merit of their idea and receive valuable advice and guidance for potential joint next steps, e.g. in form of joint pilot phases – an opportunity that money really cannot buy.
Winning the eHealth Venture Summit Innovation Award offers unparalleled clinical and commercial validation, as well as valuable exposure to an international audience that should help spur investors and other interested parties to take note of your innovation and help it progress towards benefiting patients.
The following companies are nominated:
Carmel Diagnostics (Israel)
Holoxia (United Kingdom)
Wireless Sensor Networks (Italy)
Carmel Diagnostics (Israel) Carmel Diagnostics’ product Fertissimo is a powerful enabling system that highlights the most viable embryos to conceive in IVF induced pregnancy. It utilizes proprietary Oxidative Stress (OS) technology that systemically increases probability of IVF pregnancy against an existing landscape needing multiple IVF cycles to successfully conceive. Business Model & Commercialization: Sale of the Fertissimo system at minimal margin, with higher margins made through the sale of each test; called ‘Pay-per-test’. The device and its peripheral supplies (cartridge and cuvette) will be distributed through IVF equipment distributors and IVF drug distributors with existing channels to IVF facilities www.carmel-diagnostics.com
Flowsion (Denmark) Flowsion’s product GLYCOSTAT is a complete solution for fully automated central venous blood glucose control in the ICU! Glycostat is a fully automated blood glucose controller with a Continuous Glucose Meter (CGM), an algorithm to calculate needed glucose insulin rates and a pump to administer insulin and glucose at the calculated rate to critically ill patients in the ICU; keeping their blood glucose level all the time within the desired boundaries. www.flowsion.de
Holoxia (United Kingdom) Holoxica is a "Deep Tech" company working on a disruptive holographic 3D Displays for visualizing medical images from CT, MRI & Ultrasound scanners. Our technology enables full 3D images to appear in mid-air without the need for any glasses or eye-ware. www.holoxica.com
Insulcloud (Spain) Insulcloud S.L. is a company that designs electronic devices and digital solutions based on R & D to improve monitoring of chronic diseases' treatment, in which a device is needed to administer the medication, such as diabetes, disturbances of growth, multiple sclerosis, pain respiratory, etc. www.insulclock.com
Pridiktiv (Belgium) Pridiktiv is a mobile (smartphone, tablet & desktop) communication platform, which allows caretakers and medical personnel to reduce administration time with 66%, decrease briefing time with 85% and increase the quality of care by real-time up to date information. The platform allows care institutions to tap into the collective intelligence of its care personnel with the final goal to let caretakers focus on what they do best and allow care institutions to optimize time. Pridiktiv’s communication platform focuses on 3 pillars: real-time communication between care personnel, telemetric integration of sensors and medical devices and an intelligent algorithm (AI) that predicts care issues even before they occur. www.pridiktiv.care
Protein Alternatives (Spain) Protein Alternatives (ProAlt) is a biotechnological company developing biomarker-based assays for cancer diagnosis and therapeutic monoclonal antibodies against proteins associated with metastatic tumors having poor prognosis, mainly colon, breast and melanoma. ColoDetect is a test for early screening of colorectal cancer (CRC) in medium and high risk populations (men and woman from 50-75 years old). Only 30-40% of colon cancer cases are diagnosed in early stages, when are still asymptomatic and survival rate is highly related to cancer stage at diagnosis. www.proteinalternatives.com
Quibim (Spain) QUIBIM has developed a cloud platform for providing services of advanced image analysis using artificial intelligence and proprietary algorithms for the radiologists and medical community. QUIBIM applies advanced algorithms to medical images to objectively measure disease- or treatment-derived alterations in organs and tissues, offering additional quantitative information to the naked eye of radiologists. Technology is available for hospitals and pharma companies through QUIBIM PRECISION platform. www.quibim.com
Wireless Sensor Networks (Italy) Telemetric control of oxygen delivery for therapy optimization and adherence. CRYO2 is a telemetric system serving LTOT patients, allowing the optimization of O2 delivery, patient adherence, timely identification of disease exacerbation and the continuous monitoring of vital O2 physiological variables. www.wsn4life.com
11:00 – 11:30 h Networking
11:30 – 13:35 h Introduction Dr. Stefan Becker
11:35 – 13:00 h Start-up Panel for the eHealth Venture Summit Award 2017 Chair: Prof. Dr. Jochen Werner and Prof. Dr. Talya Miron-shatz
13:00 – 13:15 h Novel uses and needs in digital health Prof. Talya Miron-shatz
13:15 - 13:55 h Funding Panel: Who funds digital health and what are they looking for? Chair: Prof. Dr. Talya Miron-Shatz
13:55 – 14:00 h Award Ceremony
Christian Piepenbrock, Innovation and Business Development Consultant, Amgen Research, Berlin, Germany
Clara Leonard, Associate, dHealth Ventures, Berlin, Germany
Jonas Pendzialek, Digital Transformation Manager Techniker Krankenkasse (TK)
Levi Shapiro, mHealth Israel, Jerusalem, Israel
Dr. Martin Pfister, High Tech Gründerfonds, Bonn, Germany